Arrowhead Pharmaceuticals
Price & Volume
Stats
See more52W Range | $9.57-$27.34 |
Market Cap | $2.8B |
Shares Short | 12M |
Financials
See moreRevenue (12 Mos) | $572.9M |
Revenue Growth (YoY) | -29.6% |
Gross Profit (12 Mos) | $572.9M |
Diluted EPS | -$1.20 |
News
See moreYahoo Finance • 5 days ago
Sarepta Therapeutics Announces Advancement of siRNA Collaboration and Sale of Arrowhead Equity Investment
Yahoo Finance • 5 days ago
Arrowhead Pharmaceuticals Redeems Approximately $50 Million of Arrowhead Stock and Will Receive Approximately $50 Million in Cash in Satisfaction of Milestone from Sarepta Therapeutics
Yahoo Finance • 7 days ago
Sarepta Therapeutics stock holds steady as TD Cowen reiterates $17 target
Yahoo Finance • 10 days ago
Arrowhead Pharma stock price target lowered to $21 at Leerink Partners
About
CEO | Dr. Christopher R. Anzalone Ph.D. |
Address | 177 East Colorado Boulevard, Pasadena, CA, United States, 91105 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 609 |
